Blockbuster potential drugs ruled the 2024 pipeline wit...
GLP-1RAs were the big game changer, boosting average forecast sales and return o...
Ionis and Sobi agree on olezarsen commercialisation
Ionis has entered a licence agreement with Sobi in which the latter obtains excl...
How bioconjugation is unlocking the next generation of ...
Bioconjugation presents an new frontier for pharmaceutical development, providin...